on Wellgistics Health, Inc. (NASDAQ:WGRX)
Wellgistics Health Ends Equity Line of Credit to Focus on Growth
Wellgistics Health, Inc., a leader in pharmaceutical distribution, has announced the termination of its equity purchase agreement with Hudson Global Ventures, LLC. This strategic shift aligns with the company's focus on accretive financing to enhance long-term shareholder value.
The company has experienced significant success in expanding its independent pharmacy network and advancing its AI-powered prescription technology. Wellgistics aims to bypass traditional PBM barriers, increase manufacturer margins, and improve patient access through this move.
According to CFO Mark DiSiena, ending the ELOC supports a disciplined capital approach, optimizing funding to align with strategic goals. CEO Brian Norton emphasizes that this decision is part of a broader strategy focused on operational strength and market capability.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Wellgistics Health, Inc. news